Company Filing History:
Years Active: 2020-2022
Title: John Thomas Loffredo: Innovator in Glypican-3 Research
Introduction
John Thomas Loffredo is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of glypican-3-binding fibronectin-based scaffold molecules. With a total of 2 patents, Loffredo's work is paving the way for advancements in diagnostic and therapeutic applications.
Latest Patents
Loffredo's latest patents focus on glypican-3-binding fibronectin-based scaffold molecules. These patents describe polypeptides that include tenth fibronectin type III domains (Fn3) that bind to glypican-3. Additionally, the patents provide fusion molecules comprising an Fn3 domain that bind to glypican-3 for use in diagnostic and therapeutic applications. Glypican-3-Fn3 drug conjugates are also included in his innovative work.
Career Highlights
John Thomas Loffredo is currently associated with Bristol-Myers Squibb Company, where he continues to contribute to groundbreaking research. His expertise in biotechnology and molecular biology has positioned him as a key player in the development of new therapeutic strategies.
Collaborations
Loffredo has collaborated with esteemed colleagues such as Dasa Lipovsek and Joseph Toth. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the field.
Conclusion
John Thomas Loffredo's contributions to glypican-3 research exemplify the importance of innovation in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic outcomes.